title: A comparative study of prostacyclin infusion given before and during cardiopulmonary bypass to assess the first pass effect of the circuit on platelet number and function.
abstract: Platelet damage during cardiopulmonary bypass (CPB), although proportional to the duration of bypass, may result in significant dysfunction after the initial contact with an extracorporeal circuit, the so-called 'first pass' phenomenon. The platelet sparing effect of prostacyclin (PGI2) infusion was studied in a double-blind randomized trial on male patients undergoing coronary artery bypass grafts to assess the effect of the 'first pass' through the CPB circuit. Prostacyclin infusion was begun before the onset of CPB or during CPB in two groups which were compared to a placebo control group. A standardized anaesthetic, surgical and perfusion technique were used. Preoperatively and during surgery at pre-set intervals, whole blood platelet aggregation was studied using ADP and collagen agonists. Platelet numbers and function measured by ADP aggregation were conserved in the two PGI2 groups. There was no significant difference between the treated groups. We conclude, therefore, that the initial contact of platelets with the CPB circuit, in the absence of PGI2 did not irreversibly affect platelet function. In addition, the hypotensive action of PGI2 was easier to control once on bypass. It may therefore be preferable to delay PGI2 infusion until CPB has been established.
authors.affiliation: Department of Haematology, Papworth Hospital, Cambridge, UK.
authors.forename: H K
authors.initials: HK
authors.lastname: Jestice
authors.forename: J E
authors.initials: JE
authors.lastname: Humphreys
authors.forename: T A
authors.initials: TA
authors.lastname: English
authors.forename: C E
authors.initials: CE
authors.lastname: Hoggarth
authors.forename: F C
authors.initials: FC
authors.lastname: Wells
mesh_terms: D000244:Adenosine Diphosphate / Q000494:pharmacology; D000328:Adult; D000368:Aged; D001792:Blood Platelets / Q000187:drug effects* / Q000473:pathology; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D003094:Collagen / Q000494:pharmacology; D011464:Epoprostenol / Q000008:administration & dosage* / Q000494:pharmacology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects
chemical_list: D000244:Adenosine Diphosphate; D003094:Collagen; D011464:Epoprostenol